March 13, 2026

HS Linked to Higher Self-Harm, Suicide Risk

Prior self-harm episodes and nonviolent methods are more common among HS patients who die by suicide, new research finds.

Conexiant

March 12, 2026

ACP Calls for Sweeping Policy Shifts on Disability in Medicine

Twin policy statements in Annals of Internal Medicine outline structural reforms aimed at improving health care access for patients with disabilities and supporting physicians with disabilities in training and practice.

Conexiant

March 12, 2026

Beyond IOP: The Mood Effects of CAIs

Evidence from large US dataset suggests topical carbonic Anhydrase Inhibitors may increase depression risk in glaucoma patients

The Ophthalmologist

March 12, 2026

Medical Oddities: Allergies, Meet Your Match in Matcha

Matcha muting sneezes, snack foods nudging fracture risk, firstborns navigating baby-number-two drama, and more this week.

Conexiant

March 10, 2026

Psilocybin Beats Nicotine Patch in Smoking Trial

A single psilocybin dose outperforms standard nicotine replacement, opening a new front in one of medicine’s most intractable problems.

Conexiant

March 10, 2026

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

Conexiant

March 05, 2026

Did Medicine Lose Its Aura Before AI?

From the clinical gaze to electronic health records, a JAMA essay traces the long technological arc that set the stage for AI in medicine.

Conexiant

March 05, 2026

Hidden Risk: Clinician Substance Use

Longitudinal Swedish study finds physicians and nurses reporting problem drinking or illicit drug use had about twice the risk of rating their care as poor 1 year later

Conexiant

March 05, 2026

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

Conexiant

March 05, 2026

Comparing Brain Stimulation Strategies for Depression

Two transcranial magnetic stimulation protocols produced different short-term outcomes in patients with major depressive disorder

Conexiant